Evoke Pharma, Inc. (EVOK)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.70M |
| Enterprise Value | 3.96M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.28 |
| Price/Book (mrq) | 1.79 |
| Enterprise Value/Revenue | 0.76 |
| Enterprise Value/EBITDA | -0.54 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.30 |
| 52-Week Change 3 | -76.76% |
| S&P500 52-Week Change 3 | 21.08% |
| 52 Week High 3 | 2.4000 |
| 52 Week Low 3 | 0.4160 |
| 50-Day Moving Average 3 | 0.5996 |
| 200-Day Moving Average 3 | 1.0354 |
Share Statistics
| Avg Vol (3 month) 3 | 40.99k |
| Avg Vol (10 day) 3 | 16.86k |
| Shares Outstanding 5 | 8.48M |
| Implied Shares Outstanding 6 | 8.7M |
| Float 8 | 4.38M |
| % Held by Insiders 1 | 9.65% |
| % Held by Institutions 1 | 37.96% |
| Shares Short (Apr 15, 2024) 4 | 36.64k |
| Short Ratio (Apr 15, 2024) 4 | 1.09 |
| Short % of Float (Apr 15, 2024) 4 | 0.44% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.43% |
| Shares Short (prior month Mar 15, 2024) 4 | 72.13k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:12 |
| Last Split Date 3 | May 23, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -150.41% |
| Operating Margin (ttm) | -112.64% |
Management Effectiveness
| Return on Assets (ttm) | -49.09% |
| Return on Equity (ttm) | -1,035.44% |
Income Statement
| Revenue (ttm) | 5.18M |
| Revenue Per Share (ttm) | 1.55 |
| Quarterly Revenue Growth (yoy) | 110.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -7.79M |
| Diluted EPS (ttm) | -2.3300 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.74M |
| Total Cash Per Share (mrq) | 0.56 |
| Total Debt (mrq) | 5M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.25 |
| Book Value Per Share (mrq) | -0.77 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4.98M |
| Levered Free Cash Flow (ttm) | -2.53M |
© 2024 Yahoo. All rights reserved.